Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00045279
Status:
COMPLETED
Last Update Posted:
2013-06-05
First Post:
2002-09-06
Brief Title:
PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Kidney Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV renal cell cancer | View |